Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06385288 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 5 months later Jul 21, 2026 → Dec 31, 2028
See other at-risk trials from University Hospital Tuebingen

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 21, 2026 to Dec 31, 2028 Show 5 more changesShow less
    • Enrollment closed, study ongoing
    • Study completion moved earlier from Jul 21, 2031 to Dec 31, 2028
    • Eligibility criteria expanded, about 9 words
    • Study description revised
    • Site details revised
  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
"Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcoma" is a prospective study with additional translational research using preoperative and postoperative tissue, blood sampling and advanced imaging.
Trial Details
NCT Number NCT06385288
Lead Sponsor University Hospital Tuebingen
Conditions
(from sponsor)		 Soft Tissue Sarcoma Adult
Related terms Sarcoma
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov